Literatuur over telebegeleiding

Boyne, Josiane & Vrijhoef, Hubertus & Gorgels, Anton. (2011). Telebegeleiding bij patiënten met hartfalen.

‘Telebegeleiding laat een duidelijke trend zien in afnamen van het aantal ziekenhuisopnamen wegens hartfalen. Patiënten met een ziektegeschiedenis van korter dan 18 maanden hartfalen, hebben de beste resultaten. Tot slot hebben patiënten met telebegeleiding minder contacten met de hartfalenverpleegkundige. Deze uitkomsten geven aan dat telebegeleiding in staat is om ziekenhuisopnames te voorkomen en contacten met zorgverleners te verminderen.’

Domingo, e.a. (2011). Noninvasive Remote Telemonitoring for Ambulatory Patients With Heart Failure: Effect on Number of Hospitalizations, Days in Hospital, and Quality of Life. CARME (Catalan Remote Management Evaluation) Study. Revista española de cardiología. 64. 277-85.

‘The Motiva telemonitoring system significantly reduced the number of hospitalizations and days in hospital for HF and other cardiac causes in patients controlled in a structured multi- disciplinary HF unit. In order to determine which patients might benefit more from a particular telemonitoring system, a larger sample, allowing for subgroup analysis, is required. Finally, patients significantly improved their perceived QoL, particularly in the physical dimension.’

Bashli et al (2017). Remote monitoring patients with heart failure: an overview of systematic reviews. JMIR. 

‘Telemonitoring and home telehealth appear generally effective in reducing heart failure rehospitalization and mortality. Other interventions, including the use of mobile phone-based monitoring and videoconferencing, require further investigation.’

Eurlings, C., Boyne, J., Boer, R., De, & Brunner-La Rocca, H. (2018, December 10). Telemedicine in heart failure—more than nice to have? Netherlands Heart Journal, 5-15.

‘In this paper, we provide a critical and an updated review of the current evidence by discussing the most important trials, meta-analyses and systematic reviews. So far, evidence for the CardioMEMS device is most convincing. Other trials regarding invasive and non-invasive telemonitoring and telephone support show divergent results, but several meta-analyses and systematic reviews uniformly reported a beneficial effect. Dutch studies showed predominantly non-significant results, mainly due to underpowered studies or because of a high standard of usual care. There are no conclusive results on cost-effectiveness of telemedicine because of the above shortcomings. The adherence of elderly patients was good in the trials, being essential for the compliance of telemedicine in the entire heart failure population. In the future perspective, telemedicine should be better standardised and evolve to be more than an addition to standard care to improve care and reduce costs.’